A new study indicates that severity of amyloid deposition in the brain—not just age—may be key to determining who will benefit from new anti-amyloid therapies to delay the progression of Alzheimer's disease.
Dec 22, 2023
0
124
Research led by UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has highlighted the need for clarity when defining late-life cognitively high performers, which could ultimately inform strategies to help prevent the development ...
Dec 18, 2023
0
51
People with long COVID exhibit patterns of changes in the brain that are different from fully recovered COVID-19 patients, according to research being presented next week at the annual meeting of the Radiological Society ...
Nov 22, 2023
0
60
A second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal confirmed its efficacy.
Jul 22, 2023
0
119
University of Cincinnati researchers are presenting abstracts at the European Stroke Organization Conference (ESOC) 2023, May 24-26 in Munich, Germany, including the results of the first large-scale assessment of radiological ...
May 26, 2023
0
80
Some of the lowest rates of heart and brain disease ever reported by science are found among Indigenous communities inhabiting the tropical forests of lowland Bolivia. New USC research on two of these societies, the Tsimané ...
Mar 21, 2023
0
131
Alzheimer's disease is the most common form of dementia, accounting for 60% to 80% of dementia cases, according to the Alzheimer's Association. While current research suggests alcohol use disorder is a risk factor in Alzheimer's ...
Feb 17, 2023
0
342
Scientists from CSIRO, Australia's national science agency, in partnership with Queensland University of Technology, have used artificial intelligence to develop a world-first benchmark for measuring brain atrophy—or thinning—in ...
Feb 1, 2023
0
58
Researchers from Indiana University School of Medicine have identified a protein that interacts and enhances the spread of neurotoxic species of tau—which is primarily found in neurons that appear abnormal in the brains of ...
Nov 17, 2022
0
122
For people with multiple sclerosis (MS), hearing a doctor tell them they are experiencing brain atrophy—an important, predictive biomarker of MS disease progression—can trigger debilitating fear and anxiety.
Nov 14, 2022
0
44
